Target intelligence / Profile preview

Human herpesvirus DNA polymerase (Pol)

Target
Pol
Molecular classification
Enzyme, DNA-directed DNA polymerase
01

Overview

Human herpesvirus DNA polymerase is a fundamental enzyme required for the replication of the double-stranded DNA genomes of all human herpesviruses, including Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), and Cytomegalovirus (CMV) [UniProt, NIH]. As a DNA-directed DNA polymerase, it catalyzes the addition of deoxyribonucleotides to the 3'-end of a growing DNA chain using a viral DNA template [UniProt]. The enzyme typically functions as part of a larger replication complex and often exhibits 3'-5' exonuclease activity, which provides a proofreading mechanism to ensure high-fidelity replication [NIH]. Because of its central role in the viral life cycle and its distinct structural features compared to human DNA polymerases, it is a major target for antiviral chemotherapy [DrugBank, StatPearls]. Most therapeutic agents, such as acyclovir and ganciclovir, are prodrugs that are phosphorylated to active triphosphate forms which then compete with natural substrates to inhibit the enzyme and cause chain termination [DrugBank, StatPearls]. Other inhibitors like foscarnet target the pyrophosphate binding site directly without requiring metabolic activation [StatPearls]. Clinical challenges associated with targeting this enzyme include the development of drug resistance through point mutations and potential toxicities such as nephrotoxicity or bone marrow suppression depending on the specific drug used [StatPearls].

Other names
Human herpesvirus viral DNA polymeraseDNA-directed DNA polymeraseUL30UL54BALF5ORF28U38ORF54Herpesvirus DNA polymerase
02

Mechanism of action

Nucleoside and nucleotide analogs act as competitive inhibitors of deoxyribonucleotide triphosphates (dNTPs) and function as DNA chain terminators upon incorporation into the nascent viral DNA strand [DrugBank, StatPearls]. Pyrophosphate analogs like foscarnet non-competitively inhibit the enzyme by binding to the pyrophosphate exchange site, preventing the cleavage of pyrophosphate from deoxynucleoside triphosphates and thus blocking DNA chain elongation [StatPearls].

03

Biological functions

Viral DNA replicationDNA synthesis3'-5' exonuclease activity
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityMyelosuppressionDrug resistanceNeurotoxicityElectrolyte imbalances
06

Interacting drugs

Acyclovir

8 more in the full profile.

07

Biomarkers

Viral DNA loadUL30 gene mutationsUL54 gene mutations

Beyond the preview

Go deeper on Human herpesvirus DNA polymerase (Pol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human herpesvirus DNA polymerase (Pol).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call